HK1108568A1 - Method of preventive treatment of allergy by mucosal administration of an allergy vaccine - Google Patents

Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Info

Publication number
HK1108568A1
HK1108568A1 HK07113823.9A HK07113823A HK1108568A1 HK 1108568 A1 HK1108568 A1 HK 1108568A1 HK 07113823 A HK07113823 A HK 07113823A HK 1108568 A1 HK1108568 A1 HK 1108568A1
Authority
HK
Hong Kong
Prior art keywords
allergy
allergen
preventive treatment
subject
mucosal administration
Prior art date
Application number
HK07113823.9A
Other languages
English (en)
Inventor
Jens Brimnes
Jens Kildsgaard
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35840082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1108568(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of HK1108568A1 publication Critical patent/HK1108568A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK07113823.9A 2004-11-10 2007-12-19 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine HK1108568A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62645404P 2004-11-10 2004-11-10
DKPA200401730 2004-11-10
US68691405P 2005-06-03 2005-06-03
PCT/DK2005/000716 WO2006050729A2 (en) 2004-11-10 2005-11-08 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Publications (1)

Publication Number Publication Date
HK1108568A1 true HK1108568A1 (en) 2008-05-09

Family

ID=35840082

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113823.9A HK1108568A1 (en) 2004-11-10 2007-12-19 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Country Status (11)

Country Link
US (1) US20060121064A1 (ja)
EP (1) EP1812059B1 (ja)
JP (1) JP5628473B2 (ja)
AT (1) ATE468135T1 (ja)
AU (1) AU2005304107B2 (ja)
CA (1) CA2586283A1 (ja)
DE (1) DE602005021388D1 (ja)
HK (1) HK1108568A1 (ja)
MX (1) MX2007005523A (ja)
PL (1) PL1812059T3 (ja)
WO (1) WO2006050729A2 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1814516B1 (en) * 2005-11-04 2012-12-26 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
AU2009203733A1 (en) * 2008-01-08 2009-07-16 Alk-Abello A/S Allergy vaccine composition for mucosal administration
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
US8802056B2 (en) * 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
US10080810B2 (en) 2008-07-17 2018-09-25 John Shea Method for testing and treating delayed food allergies
TR201906326T4 (tr) * 2010-04-30 2019-05-21 Allovate Llc Oral mukoza ile alerjik desansitizasyona yönelik diş macunu.
EP3305319A1 (en) 2010-04-30 2018-04-11 Allovate, LLC Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
BR112013009068A2 (pt) * 2010-10-15 2016-07-19 Alk Abelló As supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno
EP2627354B1 (en) * 2010-10-15 2015-07-15 ALK-Abelló A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy
CN110531059A (zh) * 2019-09-27 2019-12-03 中国海洋大学 一种食物过敏原动态消化模型和体外模拟评价方法
CN115735854A (zh) * 2022-11-15 2023-03-07 中国农业大学 一种榛子食物过敏的动物模型构建方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63159324A (ja) * 1986-12-22 1988-07-02 Lion Corp スギ花粉症用経口ワクチン
AUPM307793A0 (en) * 1993-12-22 1994-01-20 Holt, Patrick G Professor Prophylaxis of allergic disease
JPH09315998A (ja) * 1996-05-30 1997-12-09 Japan Tobacco Inc スギ花粉症の予防および／または治療剤
AU771552B2 (en) * 1999-02-05 2004-03-25 Alk-Abello A/S Novel mucosal delivery system
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
EP1504089A2 (en) * 2002-05-16 2005-02-09 Alk Abell A/S Allergen mutants
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.

Also Published As

Publication number Publication date
WO2006050729A2 (en) 2006-05-18
ATE468135T1 (de) 2010-06-15
EP1812059A2 (en) 2007-08-01
WO2006050729A3 (en) 2006-08-24
AU2005304107B2 (en) 2011-06-02
PL1812059T3 (pl) 2010-10-29
MX2007005523A (es) 2007-07-05
AU2005304107A1 (en) 2006-05-18
US20060121064A1 (en) 2006-06-08
DE602005021388D1 (de) 2010-07-01
CA2586283A1 (en) 2006-05-18
JP5628473B2 (ja) 2014-11-19
EP1812059B1 (en) 2010-05-19
JP2008519776A (ja) 2008-06-12

Similar Documents

Publication Publication Date Title
HK1108568A1 (en) Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2010030180A3 (en) Peptide formulations and uses thereof
MX2007004882A (es) Derivados de xantina con actividad de receptor de hm74a.
WO2006116731A3 (en) Personal care compositions comprising a dipeptide
EA201101187A1 (ru) Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
EA201391701A1 (ru) Назальные тестостероновые гели с контролируемым высвобождением, способы перназального введения и предварительно заполненные многодозные аппликаторные системы для перназального введения
MA32872B1 (fr) Traitement du diabete chez des patients dont la regulation glycemique est insuffisante malgre une therapie par un medicament antidiabetique oralou non oral
EA201100506A1 (ru) Комбинация ингибитора протеазы ns3 hcv с интерфероном и рибавирином
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
UA99094C2 (ru) Способ лечения пациента с системной красной волчанкой
WO2007136845A3 (en) Low-dose doxepin for treatment of sleep disorders in elderly patients
ATE407690T1 (de) Topische pharmazeutische zusammensetzungen enthaltend aktive natürliche bestandteile zur verhütung und behandlung von mucosalen entzündungprozessen
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
TW200738255A (en) Methods of regulating renalase (Monoamine Oxidase C)
ATE484292T1 (de) Chorionic gonadotropin zur behandlung des chronischen schmerzsyndroms des beckens
SE0401631L (sv) Ny sammansättning
EA200800537A1 (ru) Маррубиин и композиция для уменьшения храпа, упаковка и методика
Madhavan et al. In vitro and in vivo antioxidant activity studies on the roots of Toddalia asiatica (L.) Lam.(Rutaceae)
WO2011028799A3 (en) Ganglioside transmucosal formulations
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171108